semaglutide clinical trials Long-term weight loss effects of in obesity without diabetes in the SELECT trial New Wegovy clinical trial finds

It inhibits tyrosinase, reducing melanin production, which addresses uneven skin tone, hyperpigmentation, and improves skin texture and radiance

Already sent this off to a long list of friends/family using GLP-1s

Across all income groups, cost barriers remain the limiting factor, signaling that cost continues to dictate access more than medical need

Hair Loss Hair loss is increasingly being linked to GLP-1 RAs, with growing evidence suggesting a possible association

NAD+ homeostasis in health and disease

The combination of these three pathways produces synergistic effects that exceed what any single pathway could achieve